Effect of ranolazine on the course of ischemic heart disease after percutaneous coronary intervention
Optimization of antiischemic therapy is necessary in many patients with stable forms of coronary heart disease after or during revascularization. From the standpoint of current guidelines, the addition of second-line drugs, in particular ranolazine, to beta-blockers and/or calcium antagonists is con...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
TOV Chetverta Khvylia
2020-12-01
|
| Col·lecció: | Кардіохірургія та інтервенційна кардіологія |
| Matèries: | |
| Accés en línia: | http://www.csic.com.ua/images/pdf/2020/4-2020/effect-ranolazine-course-ischemic-heart-disease-after-percutaneous-coronary-intervention.pdf |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|